The 'Optimise' study

“优化”研究

• 批准号: nhmrc : GNT1067062
• 负责人: Ms Elizabeth Barnes
• 金额: $ 42.41万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/optimise-study/1344924
• 关键词: Optimise; study

An aspirin per day reduces cancer risk as well as protecting against heart disease and stroke. It's readily available, affordable and could potentially reduce the two most common causes of death and disease in Australia. However, aspirin also increases the chance of bleeding and that needs to be weighed up against the potential benefits. The challenge for patients and their healthcare providers is personalising this evidence for the individual patient. Our study develops and tests an online tool that does just that.

阿司匹林每天降低癌症风险，并预防心脏病和中风。它很容易获得，负担得起，并有可能减少澳大利亚的两个最常见的死亡和疾病原因。但是，阿司匹林还增加了出血的机会，并且需要权衡与潜在的好处相比。患者及其医疗保健提供者面临的挑战是为个体患者个性化这些证据。我们的研究开发和测试了一种可以做到这一点的在线工具。